Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Acura Pharmaceuticals (CE) (ACUR)

Acura Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ACUR
DateTimeSourceHeadlineSymbolCompany
21/11/202413:32Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
04/11/202420:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/10/202415:16Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
09/08/202418:44Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
26/07/202419:52Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
04/06/202415:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
15/05/202412:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
14/05/202420:40Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
14/02/202415:53Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/02/202415:27Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
10/01/202422:13Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202420:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202420:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
02/01/202420:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
21/12/202317:01Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
06/12/202319:35Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202317:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202317:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202317:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
20/11/202317:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:ACURAcura Pharmaceuticals Inc (CE)
03/11/202316:42Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
12/10/202316:05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
25/09/202320:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
01/09/202311:00Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
31/08/202320:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
30/08/202320:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
16/08/202315:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
10/08/202316:17Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:ACURAcura Pharmaceuticals Inc (CE)
28/07/202320:41Edgar (US Regulatory)Form 8-K - Current reportUSOTC:ACURAcura Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ACUR